Absence of cerebrospinal fluid oligoclonal bands is associated with delayed disability progression in relapsing-remitting MS patients treated with interferon-β
P Annunziata, A Giorgio, L De Santi, V Zipoli… - Journal of the …, 2006 - Elsevier
To assess the role of CSF oligoclonal bands (OB) in determining the clinical outcome in
patients with relapsing-remitting multiple sclerosis (RRMS) treated with IFN-β, we carried out …
patients with relapsing-remitting multiple sclerosis (RRMS) treated with IFN-β, we carried out …
The use and abuse of the cerebrospinal fluid IgG profile in the adult: a practical evaluation
LA Hershey, JL Trotter - Annals of Neurology: Official Journal of …, 1980 - Wiley Online Library
Cerebrospinal fluid (CSF) samples from 150 patients with multiple sclerosis (MS) and 190
patients with other neurological disorders were examined with a battery of tests (the IgG …
patients with other neurological disorders were examined with a battery of tests (the IgG …
Oligoclonal bands and antibody responses in multiple sclerosis
J Correale, M de los Milagros Bassani Molinas - Journal of neurology, 2002 - Springer
Multiple Sclerosis (MS) is an inflammatory disease of the Central Nervous System with
multifocal areas of demyelination. Although its etiology and pathogenesis remain …
multifocal areas of demyelination. Although its etiology and pathogenesis remain …
Randomized study of antibodies to IFN-g and TNF-a in secondary progressive multiple sclerosis
S Skurkovich, A Boiko, I Beliaeva… - Multiple Sclerosis …, 2001 - journals.sagepub.com
Studies of cytokines in multiple sclerosis (MS) have shown that immune mechanisms
connected with disturbance of the synthesis of cytokines probably play critical roles in the …
connected with disturbance of the synthesis of cytokines probably play critical roles in the …
Oligoclonal bands and MRI in clinically isolated syndromes: predicting conversion time to multiple sclerosis
RJ Ignacio, P Liliana, C Edgardo - Journal of neurology, 2010 - Springer
The objective of the study was to evaluate whether the presence of oligoclonal bands (OB)
adds information in predicting CIS conversion to clinical definite multiple sclerosis (CDMS) …
adds information in predicting CIS conversion to clinical definite multiple sclerosis (CDMS) …
Intrathecal synthesis of IgG, IgA, IgM and IgD in untreated multiple sclerosis and controls
F Lolli, I Halawa, H Link - Acta neurologica scandinavica, 1989 - Wiley Online Library
The intrathecal production (ITP) of the immunoglobulins (Ig) G, A, M and D was examined in
untreated patients with multiple sclerosis (MS) and controls. Sensitive sandwich enzyme …
untreated patients with multiple sclerosis (MS) and controls. Sensitive sandwich enzyme …
Oligoclonal band number as a marker for prognosis in multiple sclerosis
JR Avasarala, AH Cross, JL Trotter - Archives of neurology, 2001 - jamanetwork.com
The natural course of disease in multiple sclerosis varies. Multiple sclerosis that is clinically
apparent but causes minimal disability over time has been labeledbenign multiple sclerosis …
apparent but causes minimal disability over time has been labeledbenign multiple sclerosis …
Diagnostic criteria for primary progressive multiple sclerosis: a position paper
The unique clinical characteristics of primary progressive multiple sclerosis (PPMS) pose
particular diagnostic difficulties, both in excluding other causes of progressive syndromes …
particular diagnostic difficulties, both in excluding other causes of progressive syndromes …
CSF myelin basic protein, IgG and IgM levels in 101 MS patients before and after treatment with high‐dose intravenous methylprednisolone
S Frequin, F Barkhof, KJB Lamers… - Acta neurologica …, 1992 - Wiley Online Library
A total of 101 patients (62 women; 39 men) with definite MS were treated with 1000 mg
methylprednisolone (MP) intravenously for 10 consecutive days. Immediately before and …
methylprednisolone (MP) intravenously for 10 consecutive days. Immediately before and …
MRI results from the European study on intravenous immunoglobulin in secondary progressive multiple sclerosis (ESIMS)
F Fazekas, PS Sørensen, M Filippi… - Multiple Sclerosis …, 2005 - journals.sagepub.com
Background: Monthly application of high-dose intravenous immunoglobulin (IVIG) to patients
with secondary progressive multiple sclerosis (MS) showed no clinical benefit in the …
with secondary progressive multiple sclerosis (MS) showed no clinical benefit in the …